Removal of Large Hyperoleon

Show Description +

Sometimes, significant accumulation of silicone globules in the anterior chamber (hyperoleon) is seen long after vitreous surgery. Usual methods of removal include hydroexpression and viscoexpression. While the former is fraught with the risk of anterior chamber collapse, the latter is associated with the possibility of elevated IOP in the postoperative period. Removal using the vitreous cutter risks clogging of the aspiration line with silicone oil and hence early malfunction of the probe.

This video describes a new approach for removal of significant hyperoleon using the simcoe cannula (traditionally used during extracapsular cataract surgery). Simultaneous aspiration and irrigation allows for complete removal of the emulsified oil without risk of anterior chamber collapse, loss of pupillary dilation and trauma to lens (in phakic eyes).

Posted: 3/30/2017

Keywords:

Hyperoleon

Silicone Oil

Removal of Large Hyperoleon

Sometimes, significant accumulation of silicone globules in the anterior chamber (hyperoleon) is seen long after vitreous surgery. Usual methods of removal include hydroexpression and viscoexpression. While the former is fraught with the risk of anterior chamber collapse, the latter is associated with the possibility of elevated IOP in the postoperative period. Removal using the vitreous cutter risks clogging of the aspiration line with silicone oil and hence early malfunction of the probe.

This video describes a new approach for removal of significant hyperoleon using the simcoe cannula (traditionally used during extracapsular cataract surgery). Simultaneous aspiration and irrigation allows for complete removal of the emulsified oil without risk of anterior chamber collapse, loss of pupillary dilation and trauma to lens (in phakic eyes).

Posted: 3/30/2017

Keywords:

Hyperoleon

Silicone Oil

Please log in to leave a comment.

More in Retina

Staining Under Air

Frédéric Aissani, MD

Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and Graduates

Nikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

Anti-VEGF for Proliferative Sickle Cell Retinopathy

Maria Berrocal, MD and Jennifer Lim, MD

Spotlight on UNITY® VCS: UNITY for All

Sarwar Zahid, MD, FASRS; John W. Kitchens, MD; and Matthew A. Cunningham, MD, FASRS